FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896915104> ?p ?o ?g. }

• W2896915104 endingPage "267" @default.
• W2896915104 startingPage "261" @default.
• W2896915104 abstract "Introduction . To summarize our fifteen-years clinical experience of using Botox in strabismology and determine the indications for the most effective use of chemodenervation in the complex treatment of oculomotor system pathology. Patients and methods . To carry out chemodenervation of extraocular muscles, Botox was used. The optimal dose of Botox for intramuscular injection ranged from 1.25 to 5.0 units. The choice of dosage depends on the patient’s age, the type oculomotor system pathology, the level of muscular dysfunction and the purpose of the treatment. The treatment was performed in 376 patients with various disorders of oculomotor system. At the time of treatment, the patients’ ages ranged from 12 to 78 years. Injection of Botox into the extraocular muscles in all cases was the primary method of treatment. Results . In general, the state of relative functional recovery was achieved in 71.81% of cases (in 270 patients). The best results were obtained in treatment of decompensated heterophories, acute heterotrophies, atypical heterotrophies and primary hyperfunction of the inferior oblique muscles (in 100% of cases). In these conditions, the binocular vision was preserved in patients, and the imbalance of the oculomotor system did not show any sign of incomitance. However, patients with paralysis and paresis of the cranial nerves chemodenervation allowed creating conditions for a more complete restoration of muscular functions, to avoid the occurrence of a secondary imbalance in the oculomotor system. In 70.3% cases (185 patients), subsequent surgical treatment was not required. Reliable functional results of treatment allowed creating the optimal algorithm for chemodenervation. Discussion . Chemodenervation of extraocular muscles is an effective independent and additional method of complex treatment of oculomotor system pathology and expands opportunities in patients’ rehabilitation. To achieve maximum functional results, it is necessary to select patients correctly for this procedure, taking into account its appropriateness and advantages over alternative methods of treatment, selection of optimal dosages of Botox." @default.
• W2896915104 created "2018-10-26" @default.
• W2896915104 creator A5008265140 @default.
• W2896915104 creator A5013823117 @default.
• W2896915104 creator A5040062386 @default.
• W2896915104 creator A5048226436 @default.
• W2896915104 creator A5057570108 @default.
• W2896915104 creator A5079239046 @default.
• W2896915104 date "2018-07-28" @default.
• W2896915104 modified "2023-10-15" @default.
• W2896915104 title "Botox’s Place in the Complex Treatment of Oculomotor System Pathology (the Optimal “Portrait” of the Patient for the Chemodenervation)" @default.
• W2896915104 cites W1575049096 @default.
• W2896915104 cites W1976873993 @default.
• W2896915104 cites W1981706768 @default.
• W2896915104 cites W1981923662 @default.
• W2896915104 cites W2054095305 @default.
• W2896915104 cites W2072347356 @default.
• W2896915104 cites W2150347189 @default.
• W2896915104 cites W2332962578 @default.
• W2896915104 cites W2601350471 @default.
• W2896915104 cites W2602094610 @default.
• W2896915104 cites W2726362090 @default.
• W2896915104 cites W2749597059 @default.
• W2896915104 doi "https://doi.org/10.18008/1816-5095-2018-2s-261-267" @default.
• W2896915104 hasPublicationYear "2018" @default.
• W2896915104 type Work @default.
• W2896915104 sameAs 2896915104 @default.
• W2896915104 citedByCount "1" @default.
• W2896915104 countsByYear W28969151042022 @default.
• W2896915104 crossrefType "journal-article" @default.
• W2896915104 hasAuthorship W2896915104A5008265140 @default.
• W2896915104 hasAuthorship W2896915104A5013823117 @default.
• W2896915104 hasAuthorship W2896915104A5040062386 @default.
• W2896915104 hasAuthorship W2896915104A5048226436 @default.
• W2896915104 hasAuthorship W2896915104A5057570108 @default.
• W2896915104 hasAuthorship W2896915104A5079239046 @default.
• W2896915104 hasBestOaLocation W28969151041 @default.
• W2896915104 hasConcept C118487528 @default.
• W2896915104 hasConcept C141071460 @default.
• W2896915104 hasConcept C153050134 @default.
• W2896915104 hasConcept C2776807875 @default.
• W2896915104 hasConcept C2778879792 @default.
• W2896915104 hasConcept C2781007269 @default.
• W2896915104 hasConcept C71924100 @default.
• W2896915104 hasConceptScore W2896915104C118487528 @default.
• W2896915104 hasConceptScore W2896915104C141071460 @default.
• W2896915104 hasConceptScore W2896915104C153050134 @default.
• W2896915104 hasConceptScore W2896915104C2776807875 @default.
• W2896915104 hasConceptScore W2896915104C2778879792 @default.
• W2896915104 hasConceptScore W2896915104C2781007269 @default.
• W2896915104 hasConceptScore W2896915104C71924100 @default.
• W2896915104 hasIssue "2S" @default.
• W2896915104 hasLocation W28969151041 @default.
• W2896915104 hasOpenAccess W2896915104 @default.
• W2896915104 hasPrimaryLocation W28969151041 @default.
• W2896915104 hasRelatedWork W1980886355 @default.
• W2896915104 hasRelatedWork W2022734312 @default.
• W2896915104 hasRelatedWork W2033266202 @default.
• W2896915104 hasRelatedWork W2049474579 @default.
• W2896915104 hasRelatedWork W2054633556 @default.
• W2896915104 hasRelatedWork W2089401500 @default.
• W2896915104 hasRelatedWork W2097644469 @default.
• W2896915104 hasRelatedWork W2288971696 @default.
• W2896915104 hasRelatedWork W2550577589 @default.
• W2896915104 hasRelatedWork W4207018220 @default.
• W2896915104 hasVolume "15" @default.
• W2896915104 isParatext "false" @default.
• W2896915104 isRetracted "false" @default.
• W2896915104 magId "2896915104" @default.
• W2896915104 workType "article" @default.